RSV Monoclonal Antibodies: A Paradigm Shift in Infant Protection

RSV Monoclonal Antibodies: A Paradigm Shift in Infant Protection Review Abstract Purpose: This review examines the evolving role of long-acting respiratory syncytial virus monoclonal antibodies in preventing RSV lower respiratory tract disease in infants and selected young children. Methodology: This article reviews current CDC and

RSV Monoclonal Antibodies: A Paradigm Shift in Infant Protection